ArticleMolecular oncology2015

Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.

Qiang Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.